Free Trial
NASDAQ:CDIO

Cardio Diagnostics 8/14/2025 Earnings Report

Cardio Diagnostics logo
$3.63 -0.39 (-9.70%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$3.64 +0.02 (+0.41%)
As of 08/15/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardio Diagnostics EPS Results

Actual EPS
-$0.97
Consensus EPS
-$1.80
Beat/Miss
Beat by +$0.83
One Year Ago EPS
N/A

Cardio Diagnostics Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
$0.08 million
Beat/Miss
Missed by -$65.00 thousand
YoY Revenue Growth
N/A

Cardio Diagnostics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Cardio Diagnostics' next earnings date is estimated for Monday, August 18, 2025, based on past reporting schedules.

Conference Call Resources

Cardio Diagnostics Earnings Headlines

Cardio Diagnostics (NASDAQ:CDIO) Upgraded at Wall Street Zen
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Cardio Diagnostics (CDIO) to Release Quarterly Earnings on Monday
Cardio Diagnostics Holdings, Inc. (CDIOW) - Yahoo Finance
See More Cardio Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cardio Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardio Diagnostics and other key companies, straight to your email.

About Cardio Diagnostics

Cardio Diagnostics (NASDAQ:CDIO) develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

View Cardio Diagnostics Profile

More Earnings Resources from MarketBeat